← Back
Data updated: Mar 10, 2026
MISEMER
ImmunologyGastroenterology
MISEMER is a generic drug manufacturer focused on Immunology, Gastroenterology.
1993
Since
3
Drugs
-
Trials
14
Approved (2yr)
Recent Activity
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE 2024-12-19
Labeling
KETOPROFEN 2024-11-22
Labeling
KETOPROFEN 2024-11-21
Labeling
FENOPROFEN CALCIUM 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
FENOPROFEN CALCIUM 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
FENOPROFEN CALCIUM 2024-11-21
Labeling
FENOPROFEN CALCIUM 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
1 drugs
Gastroenterology 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 1993-01-29
- Latest
- 2024-11-22
- Applications
- 3